Cite
Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections.
MLA
Li, Yuan-Yuan, et al. “Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections.” Infectious Diseases & Therapy, vol. 13, no. 4, Apr. 2024, pp. 861–74. EBSCOhost, https://doi.org/10.1007/s40121-024-00956-9.
APA
Li, Y.-Y., Chen, Y., Li, S., An, R., Hu, X.-Y., Jiang, W., Wang, C.-Y., Dong, R., Yang, Q.-W., Weng, L., Peng, J.-M., & Du, B. (2024). Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections. Infectious Diseases & Therapy, 13(4), 861–874. https://doi.org/10.1007/s40121-024-00956-9
Chicago
Li, Yuan-Yuan, Yan Chen, Shan Li, Ran An, Xiao-Yun Hu, Wei Jiang, Chun-Yao Wang, et al. 2024. “Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections.” Infectious Diseases & Therapy 13 (4): 861–74. doi:10.1007/s40121-024-00956-9.